PDF-ikonPrintikon

Mads Melbye, Professor, MD, DMSc

Mads Melbye
President, CEO
Statens Serum Institut
5 Artillerivej , 33/
DK-2300 Copenhagen S
Denmark
+45 3268 3268
Phone:
+4532683163
E-mail:

Responsibilities

President, CEO at Statens Serum Institut  

 

Education
Medical Diploma (MD), 1984
DMSc, 1988

 

Employments
2016- President & CEO, Statens Serum Institut
2015-2016 Director, Division of Epidemiology and Disease Surveillance, SSI
2014 - Professor in Medical Epidemiology, University of Copenhagen
2013- Consulting Professor, Stanford University School of Medicine
2012-15 Director, Division of National Health Surveillance and Research, SSI
2004-2012 Director, Division of Epidemiology, SSI
1998-2008 Foreign adjunct professor, Karolinska Institutet, Stockholm
1992- Head, Dept of Epidemiology Research, SSI
1998-2002 NorFA professor
1992-1997 Professor (personal chair given by the Minister of Education, Bertel Haarder, 'superprofessor')
1991-92 State epidemiologist, Dept of Epidemiology, SSI
1988-91 Senior Investigator, Institute of Cancer Epidemiology, The Danish Cancer Registry
1986-88 Intern and resident in Medicine, University Hospital, Aarhus and Copenhagen
1985-86 Visiting scientist, Environmental Epidemiology Branch, National Cancer Institute, NIH, Bethesda
1984-85 Research Fellow, The Institute of Cancer Research, Aarhus
1981-82 Holder of scholarship, The Institute of Cancer Research, Aarhus

 

Committees (selected)
2017- Chairman, Governing Council, International Agency for Research on Cancer (IARC), WHO
2016- Vice Chairman, Governing Council, International Agency for Research on Cancer (IARC), WHO
2014- Member of the International Scientific Advisory Board, UK Biobank
2012-14 Chairman, Board of Scientific Councillors, International Agency for Research on Cancer (IARC), WHO
2011- Member of Lægevidenskabens Fremme, AP Møller og hustru Chastine Mc-Kinney Møllers Fond
2007- Medlem af Novo Nordisk Priskomitéen
2007-2010 Chairman, Board of the Nordic Medical Research Councils (NOS-M)
2005- Chairman of the scientific committee, the Danish Health Insurance Fond
2006-2010 Vice-Chairman, Danish Medical Research Council
2004-2006 Member of the Danish Medical Research Council
2002-2012 Chairman, Ministry of Science, Technology and Innovation's coordinating group regarding registry
2000-2001 Chairman, Ministry of Research and Technology's working group on registry research
1999-2002 Member of the Ministry of Health's Working Group on Biobanks
1997-2010 Member of the Danish National Health Service Expert Panel regarding national cancer registration
1982-2002 Member of the Danish National Health Service Working Group on AIDS

 

Research
Research interests include infectious disease epidemiology, effects of vaccines, genetic disposition to disease, perinatal epidemiology and cancer epidemiology.
Mads Melbye has great experience with research based on the Danish registers and biobanks.
He has written more than 550 scientific articles and has an H-index of 81 in Web of Science.

 

Prizes
2014: The Erhoff Prize
2005: The Novo Nordisk Prize
1998: The Thorvald Madsen Prize
1993: Ipsen lecture
1992: The Anders Jahre Prize, Oslo, Norge
1989: AIDS fondens pris
1985: The Hjortenberg Foundation Prize
1983: Awarded gold medal of the University of Aarhus, Denmark, for a thesis on microbiology and oncology

Selected publications

Behrens I, Basit S, Lykke JA, Ranthe MF, Wohlfahrt J, Bundgaard H, Melbye M, Boyd HA. Association between hypertensive disorders of pregnancy and later risk of cardiomyopathy. JAMA 2016;315:1026-33
Charlton BM, Mølgaard-Nielsen D, Svanström H, Wohlfahrt J, Pasternak B and Melbye M. Maternal use of oral contraceptives and risk of birth defects in Denmark: prospective, nationwide cohort study. BMJ 2016;352:doi:hhtp://dx.doi.org/10.1136/mbj.h6712
Mølgaard-Nielsen D, Svanström H, Melbye M, Hviid A, Pasternak B. The association between use of oral fluconazole during pregnancy and risk of spontaneous abortion and stillbirth. JAMA 2016;315:58-67
Feenstra B, Pasternak B, Geller F, Carstensen L, Wang T, Huang F, Eitson JL, Hollegaard MV, Svanström H, Vestergaard M, Hougaard D, Schoggins JW, Jan LY, Melbye M and Hviid A. Common variants associated with general and MMR vaccine-related febrile seizures. Nat Genet 2014;46:1274-1282
Geller F, Feenstra B, Carstensen L, Pers TH, van Rooij IALM, Körberg IB, Choudhry S, Karjalainen J, Schnack T, Hollegaard MV, Feitz WFJ, Roeleveld N, Hougaard D, Hirschhorn JN, Franke L, Baskin LS, Nordenskjöld A, van der Zanden LFM, Melbye M. Genome-wide association analyses identify variants in developmental genes associated withy hypospadias. Nat Genet 2014;46:957-63
Lund M, Pasternak B, Davidsen RB, Feenstra B, Krogh C, Wohlfahrt J and Melbye M. Use of macrolides in mother and child and risk of pyloric stenosis: Nationwide Cohort Study. BMJ 2014;348:g1908
Hviid A, Melbye M, Pasternak B. Use of selective serotonin reuptake inhibitors during pregnancy and risk of autism. N Engl J Med 2013;369:2406-15
Feenstra B, Geller F, Carstensen L, Romitti PA, Körberg IB, Bedell B, Krogh C, Fan R, Svenningson A, Caggana M, Nordenskjöld A, Mills JL, Murray JC, Melbye M. Plasma lipids, genetic variants near APOA1, and the risk of infantile hypertrophic pyloric stenosis. JAMA 2013;310:714-21
Feenstra B, Geller F, Krogh C, Hollegaard MV, Gørtz S, Boyd HA, Murray JC, Hougaard DM, Melbye M. Common variants near MBNL1 and NKX2-5 are associated with infantile hypertrophic pyloric stenosis. Nat Genet 2012;44:334-7.
Biggar RJ, Wohlfahrt J, Oudin A, Hjuler T, Melbye M.
Digoxin use and the risk of breast cancer in women. J Clin Oncol 2011;29:2165-70
Krogh C, Fischer TK, Skotte L, Biggar RJ, Øyen N, Skytthe A, Gørtz S, Christensen K, Wohlfahrt J, Melbye M. Familial aggregation and heritability of pyloric stenosis. JAMA 2010; 303:2393-2399
Edgren G, Hjalgrim H, Reilly M, Tran TN, Rostgaard K, Shanwell A, Titlestad K, Adami J, Wikman A, Jersild C, Gridley G, Wideroff L, Nyrén O, Melbye M. Risk of cancer after blood transfusion from donors with subclinical cancer. Lancet 2007; 369:1724-1730
Ahlgren M, Melbye M, Wohlfahrt J and Sørensen TIA. Growth patterns and risk of breast cancer. N Engl J Med 2004;351:1619-1626
Madsen KM, Vestergaard M, Schendel D, Wohlfahrt J, Thorsen P, Olsen J, Melbye M. A population-based study of measles, mumps and rubella vaccination and autism. N Engl J Med 2002; 347:1477-1482
Mortensen PB, Pedersen CB, Westergaard T, Wohlfahrt J, Ewald H, Mors O, Andersen PK, Melbye M. Effect of family history and place and season at birth on the risk of schizophrenia. N Engl J Med 1999; 340:603-608
Frisch M, Glimelius B, van den Brule AJC, Wohlfahrt J, Meijer CJLM, Walboomers JMM, Adami HO, Melbye M. A sexually transmitted infection as a cause of anal cancer. N Engl J Med 1997; 337:1350-1358
Melbye M, Wohlfahrt J, Olsen JH, Frisch M, Westergaard T, Larsen KH, Andersen PK. Induced abortion and the risk of breast cancer. N Engl J Med 1997; 336:81-85
Melbye M, Sprøgel P. Aetiological parallel between anal cancer and cervical cancer. Lancet 1991; 338:657-659
Melbye M, Froebel K, Madhok R, Biggar RJ, Sarin P, Stenbjerg S, Lowe C, Forbes CD, Goedert JJ, Gallo RC, Ebbesen P. HTLV-III seropositivity in European haemophiliacs exposed to factor VIII concentrate imported from the USA. Lancet 1984; ii:1444-1446

Publikationer

Link til Pub Med